Marianne Zhen, Theravance's Chief Accounting Officer, recently acquired 10,305 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on March 29, 2021. Zhen now owns 38,399 shares of the company. Zhen operates out of Burlingame, CA. Some additional info was provided as follows:
The Reporting Person was granted a time-based restricted stock award ("RSA"). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2022, 6.25% on May 20, 2022, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensa
tion Committee of the Board of Directors of the Company.
The Reporting Person was granted options. Twenty-five percent of the options shall vest on February 20, 2022, 6.25% on May 20, 2022, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensation Committee of the Board of Directors of the Company.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
